Furthermore, genetic data strongly support a causal, triggering role for aggregation and accumulation of Aβ in AD (Kunkle et al, 2019)—including the well-studied APOE4 risk allele in late-onset AD, which reduces the clearance of Aβ from the brain (Liu et al, 2013). The gene discussed is APOE; the disease is Alzheimer disease.